Saqr Alsakarneh, MD, MSc

I am so thrilled and honored to join the @MayoClinicGIHep family for my #GIFellowship! I am eternally grateful and thankful to my parents, family 🇺🇸 🇯🇴, friends, colleagues, patients, nurses, and mentors who believed in me ❤️ Here to the new beginnings! @umkcIM…

I can’t think of anybody more deserving than the 🌟 genius @IrisWangMD ! Please vote 🗳️ for Dr. Wang:) #GITwitter #MedEd #MedTwitter @MayoClinicGIHep

Floored to be included in this list!! Thank you @HealioGastro for considering me! Please help vote! 🙏🙏 @MayoClinicGIHep

Honored and delighted to receive the 2025 #ACG Outstanding Research Award in the GI Bleeding Category! 🏆 Thankful to my mentors and collaborators who made this happen! This one is really special as it is the first award I receive as a GI fellow @MayoClinicGIHep! #ACG2025…

🚨 📝 Check out our new publication assessing risk of post-ERCP complications in CF patients. Read it here: annalsgastro.gr/files/journals…

New publication 🚨 Are patients with cystic fibrosis (CF) at increased risk of post-ERCP complications? We found that: 📌 Patients with CF have similar risk for post-ERCP pancreatitis, bleeding, and infection! 📌Sensitivity analysis confirmed the results in a subgroup with…

Long-term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results Levy, et al. 📕 doi.org/10.14309/ajg.0… @DrCynthiaLevy @CholestasisDoc @clbowlus @macarlotal @DrAliyaMD @kremer_andreas @MLongMD @JasmohanBajaj

Thrilled to announce that I’ll be presenting 9 abstracts as first author at #ACG2025 in Phoenix, AZ! 🌵📊 Honored to share our work on Disparities, Achalasia, ERCP safety, EUS timing, GLP-1s, IBD, stool DNA testing & more. Grateful to my mentors and collaborators!…

First 2 weeks of fellowship @MayoClinicGIHep in the books - feeling incredibly lucky to train alongside such 🌟 co-fellows Grateful to our PD @DougSimonetto and APD @IrisWangMD for a seamless start 🥰 Excited for what the next 3 years hold! #GITwitter #MedEd #MedTwitter…

Celebrating 27 years of the #DEU! Since 1998, our team has driven innovation in endoscopy with seamless transition to clinical care, and trained leaders in the field of endoscopy. Here's to past breakthroughs which now benefit patients every day—and those still to come!…

So exciting to welcome back @MagnusHallandMD as a guest speaker to kick off our @MayoClinicGIHep fellows summer core curriculum! The packed house with rapt attention is a clear testament to his teaching reputation & excellent delivery!

Patients With IBD Are at Increased Risk of RSV Infections After SARS-CoV-2 Infection: A Propensity-Matched Cohort Analysis @AlsakarnehSaqr & @OscarRamirezMD, et al.   ➡️ bit.ly/4eej4oY @JHashashMD @FarrayeIBD @dr_fcalderaibd

New Publication 🚨 in @IBDJournals In this real world data we show that patients with Crohn’s disease who underwent Terminal Ileum (TI) resection are at increased risk of CRC: 📌CD with TI resection vs without resection (aHR: 2.58 , p<0.01) 📌CD with TI resection and disease…

Good point! Lesion is Paris IIc. But second picture shows effaced blood vessels. High risk of adenoca- as in this case. ESD outcomes not well defined in this morphology. Refs in reply

70M pancolitis+PSC, on ADAL, o/w healthy 🔦Surv CLN: depressed lesion in sigmoid (📸 👆🏽) 🔬Bx of the lesion: high grade dysplasia. Random bx proximal rectum: indefinite dysplasia, distal rectum: nml What do you recommend?  🔑TPC= total proctocolectomy; IRA= ileorectal anastomosis

Liver Transplantation Is Associated With a Reduced Risk of Colorectal Dysplasia in Patients with #IBD and #PSC sciencedirect.com/science/articl… @NayantaraCoelho @AshwinMDIBD @AGA_CGH

He is the absolute BEST @BilalMohammadMD 🔥 He has shaped careers of countless trainees including mine! @AmCollegeGastro @CUGastroHep @nataliejowilson @TGHermanMD @AlsakarnehSaqr @BalissMichelle @KAlsabb @MouhandMD @mabdallahmd @NickMcDonaldMD @fouadsjaber @SuchapaAraya